HormoneSynergy® Powered by RetzlerRx®

Longevity Medicine, Functional Wellness & Anti-Aging Insights from HormoneSynergy®

Welcome to the HormoneSynergy® Longevity Medicine Blog, a physician-guided clinical library led by Dr. Kathryn Retzler. Our articles cover the systems that most often shape health with age: metabolic health, hormones, cardiovascular and kidney risk, body composition, bone and muscle, brain health, sleep, gut health, nutrition, supplements, and the biology of aging.

The library is organized around clinical questions rather than trends. Some articles review new research. Others explain testing, treatment, nutrition, or a condition patients commonly encounter. Across the collection, the standard is the same: evidence first, appropriate uncertainty, and enough clinical context to separate useful medicine from wellness marketing.

Start with the HormoneSynergy® Longevity Medicine Framework

New & recently updated:

Metabolic Health & Insulin Resistance

Clinical resources on insulin resistance, glucose regulation, metabolic syndrome, visceral fat, prediabetes, obesity and GLP-1-based care within a broader longevity medicine plan.

Kidney Health & Cardiovascular-Kidney-Metabolic Health

Kidney health belongs in the same clinical conversation as blood pressure, diabetes, insulin resistance, obesity and cardiovascular risk. These resources cover early detection, CKD, albuminuria, nutrition and CKM health.

Gut Health, Microbiome & Immune Signaling

Clinical education on the microbiome, intestinal barrier, fiber, inflammation, gut-brain signaling, immune biology and the growing connections between gut, metabolic and kidney health.

Food Quality, Vitamins, Supplements & Wellness Claims

Evidence-based guidance on nutrient gaps, supplement quality, interactions, food claims and longevity products, with an emphasis on where supplementation helps and where marketing outruns the evidence.

  • Alzheimer's Research Is Moving Toward Earlier Intervention: Can Prevention Begin Before Memory Changes?

    HormoneSynergy® editorial image illustrating Alzheimer's prevention research, brain vascular health, genetic susceptibility, and earlier clinical intervention.

    Alzheimer's research is moving earlier in the disease process, with prevention trials investigating people who have no cognitive symptoms but may have elevated biological or genetic risk. HormoneSynergy® examines the October 2026 clinical-trials update, APOE4, emerging blood biomarkers, metabolic and vascular health, and what preventive longevity medicine can reasonably address today.

  • Pendulum™ Gut Fuel: Feeding the Microbiome Through Resistant Starch, Prebiotic Fiber, and Polyphenols

    Fiber-rich breakfast featuring oats, berries, seeds, and prebiotic nutrition illustrating Pendulum Gut Fuel, resistant starch, Akkermansia, and microbiome support for healthy aging.

    A healthy gut microbiome depends on more than introducing beneficial bacteria. It also requires the right nutritional environment. Pendulum™ Gut Fuel combines resistant potato starch, acacia fiber, baobab, oat bran, and grape seed polyphenols to support microbial activity, digestive regularity, and the metabolic pathways connecting the gut with whole-body health. HormoneSynergy® examines the formulation, the clinical research, and its potential place in a preventive longevity medicine strategy.

  • The Heart–Kidney–Metabolic Connection: A More Complete Approach to Preventive Medicine

    HormoneSynergy® preventive longevity medicine editorial showing the interconnected roles of cardiovascular, kidney, and metabolic health.

    Heart disease, kidney dysfunction, and metabolic disease often develop together, long before symptoms appear. HormoneSynergy® examines how ApoB, insulin resistance, visceral fat, kidney testing, and vascular imaging contribute to a more complete understanding of cardiovascular–kidney–metabolic risk.

  • Urolithin A: Mitochondrial Health, Brain Blood Flow, and What Human Trials Actually Show

    HormoneSynergy® editorial illustration of mitochondrial function and cerebral vascular responses in emerging urolithin A research.

    A new October 2026 randomized trial found that urolithin A altered brain blood-flow responses during cognitive testing without significantly improving peripheral endothelial function or cognitive performance. HormoneSynergy® examines the findings alongside previous human studies of mitochondrial health, muscle function, and aging.

  • GLP-1 Medications and Biological Aging: Are We Looking Beyond Weight Loss?

    HormoneSynergy editorial image illustrating research into GLP-1 medications, cellular aging, metabolic health, and longevity in older adults.

    New research published in Nature suggests that semaglutide may influence biological aging beyond its effects on weight and glucose. Dr. Kathryn Retzler examines the animal findings, the human cardiovascular and metabolic evidence, and what GLP-1 medications may eventually contribute to preventive longevity medicine.

  • Which Diet Is Right for You? Beyond the Diet Wars

    Adults sharing a protein-conscious Mediterranean meal with vegetables, fish, legumes, olive oil, and whole grains, illustrating nutrition for healthy aging.

    Mediterranean, ketogenic, vegan, carnivore, and other diets each have devoted advocates. The evidence for long-term health, however, is not equally strong across them. We examine why HormoneSynergy® favors plant-forward Mediterranean nutrition with adequate protein, and when individual health needs justify a different approach.

  • Aria's Philosophy of Being: Who Would You Be If You Didn't Know Who You Were?

    Aria, a black Shepadoodle with a white beard, rests on her doghouse beneath the stars, contemplating identity, aging, and the philosophy of simply being.

    After overhearing Daniel listening to Alan Watts and reflecting on identity, attachment, and aging, Aria begins considering a question humans rarely ask themselves: who would we be without everything we've been taught to believe about who we are?

  • Forget “Ferritin Face”: The Important Story Is That the Definition of Iron Deficiency Just Changed

    Physician reviewing ferritin and iron laboratory results with a patient at HormoneSynergy® in Lake Oswego, Oregon, illustrating the 2026 ASH iron deficiency guidelines.

    “Ferritin Face” may be trending on social media, but your appearance cannot diagnose iron deficiency. The more important development is new 2026 guidance from the American Society of Hematology that raises the ferritin threshold used to identify iron deficiency in adults. Here is what changed, why ferritin can be low even without anemia, and why interpreting iron studies requires more than looking at a laboratory reference range.

  • Applied Kinesiology: When Does Muscle Testing Become a Diagnostic Claim?

    Evidence-based review of Applied Kinesiology and manual muscle testing, including blinded research on nutritional and nonmusculoskeletal diagnostic claims.

    Manual muscle testing has legitimate clinical uses. Applied Kinesiology extends that familiar exam into claims about nutrition, hormones, gut function and internal organs. When those claims are tested under blinded conditions, the results are far less convincing.

  • When Health Starts Determining the Size of Your Life

    Daniel Soule stargazing beside a telescope under the moon and Andromeda Galaxy, illustrating healthy aging, curiosity, travel, and preserving the ability to keep exploring life.

    At some point in midlife, health stops being something we assume we have and starts determining what we are still able to do. Daniel Soule reflects on watching that divergence appear among people his own age—and why preventive medicine increasingly feels less like longevity optimization and more like protecting the freedom to keep participating in life.

  • Repatha®: What It Does, Who It’s For, and What the Evidence Shows

    Repatha evolocumab PCSK9 inhibitor illustration showing LDL particle reduction and coronary atherosclerotic plaque for HormoneSynergy preventive cardiology.

    Repatha® (evolocumab) is a PCSK9 inhibitor that can lower LDL cholesterol and ApoB substantially, reduce cardiovascular events, and produce measurable changes in coronary plaque. Here is where it fits alongside statins, ezetimibe and bempedoic acid, including what we know about statin intolerance, familial hypercholesterolemia, Lp(a), cognition, injections, cost and insurance coverage.

  • Himalayan Tartary Buckwheat and Brain Health: What a New 662-Person HTB Activ™ Trial Found

    Himalayan Tartary buckwheat and Big Bold Health HTB products featured with new clinical trial findings on cognition, sleep and fatigue

    A new randomized, double-blind, placebo-controlled trial of HTB Activ™, a sprouted Himalayan Tartary buckwheat powder rich in polyphenols such as rutin and quercetin, reports encouraging improvements in cognition, sleep, fatigue and cognitive reaction time over 90 days. Here is what the research adds to the growing interest in Himalayan Tartary buckwheat, polyphenols, brain health and healthy aging—and where diet and lifestyle still belong.